Analysen zu Apple Inc.
| 09.04.25 | Apple Hold | Jefferies & Company Inc. | |
| 07.04.25 | Apple Neutral | UBS AG | |
| 07.04.25 | Apple Overweight | JP Morgan Chase & Co. | |
| 03.04.25 | Apple Underperform | Jefferies & Company Inc. | |
| 01.04.25 | Apple Neutral | UBS AG | |
| 24.03.25 | Apple Neutral | UBS AG | |
| 18.03.25 | Apple Buy | Goldman Sachs Group Inc. | |
| 04.03.25 | Apple Overweight | JP Morgan Chase & Co. | |
| 04.03.25 | Apple Neutral | UBS AG | |
| 03.03.25 | Apple Neutral | UBS AG | |
| 24.02.25 | Apple Neutral | UBS AG | |
| 20.02.25 | Apple Buy | Goldman Sachs Group Inc. | |
| 19.02.25 | Apple Neutral | UBS AG | |
| 17.02.25 | Apple Neutral | UBS AG | |
| 17.02.25 | Apple Buy | Goldman Sachs Group Inc. | |
| 04.02.25 | Apple Neutral | UBS AG | |
| 31.01.25 | Apple Halten | DZ BANK | |
| 31.01.25 | Apple Underperform | Jefferies & Company Inc. | |
| 31.01.25 | Apple Underweight | Barclays Capital | |
| 31.01.25 | Apple Buy | Merrill Lynch & Co., Inc. | |
| 31.01.25 | Apple Neutral | UBS AG | |
| 31.01.25 | Apple Buy | Goldman Sachs Group Inc. | |
| 24.01.25 | Apple Neutral | UBS AG | |
| 21.01.25 | Apple Underperform | Jefferies & Company Inc. | |
| 06.01.25 | Apple Overweight | JP Morgan Chase & Co. | |
| 06.01.25 | Apple Neutral | UBS AG | |
| 03.01.25 | Apple Neutral | UBS AG | |
| 02.01.25 | Apple Neutral | UBS AG | |
| 16.12.24 | Apple Overweight | JP Morgan Chase & Co. | |
| 29.11.24 | Apple Neutral | UBS AG | |
| 20.11.24 | Apple Neutral | UBS AG | |
| 19.11.24 | Apple Overweight | JP Morgan Chase & Co. | |
| 15.11.24 | Apple Hold | Jefferies & Company Inc. | |
| 07.11.24 | Apple Neutral | UBS AG | |
| 04.11.24 | Apple Overweight | JP Morgan Chase & Co. | |
| 01.11.24 | Apple Halten | DZ BANK | |
| 01.11.24 | Apple Hold | Jefferies & Company Inc. | |
| 01.11.24 | Apple Neutral | UBS AG | |
| 30.10.24 | Apple Neutral | UBS AG | |
| 28.10.24 | Apple Hold | Jefferies & Company Inc. | |
| 28.10.24 | Apple Overweight | JP Morgan Chase & Co. | |
| 22.10.24 | Apple Neutral | UBS AG | |
| 21.10.24 | Apple Hold | Jefferies & Company Inc. | |
| 16.10.24 | Apple Neutral | UBS AG | |
| 16.10.24 | Apple Hold | Jefferies & Company Inc. | |
| 14.10.24 | Apple Overweight | JP Morgan Chase & Co. | |
| 09.10.24 | Apple Neutral | UBS AG | |
| 07.10.24 | Apple Overweight | JP Morgan Chase & Co. | |
| 07.10.24 | Apple Hold | Jefferies & Company Inc. | |
| 04.10.24 | Apple Overweight | JP Morgan Chase & Co. |
Aktuelle Aktienanalysen
| 15.12.25 | Nestlé Neutral | UBS AG | |
| 15.12.25 | Novo Nordisk Neutral | UBS AG | |
| 15.12.25 | Sanofi Buy | UBS AG | |
| 15.12.25 | Sanofi Overweight | Barclays Capital | |
| 15.12.25 | arGEN-X Overweight | JP Morgan Chase & Co. | |
| 15.12.25 | UBS Buy | Deutsche Bank AG | |
| 15.12.25 | Ströer Buy | Warburg Research | |
| 15.12.25 | Roche Hold | Deutsche Bank AG | |
| 15.12.25 | Sanofi Buy | Jefferies & Company Inc. | |
| 15.12.25 | Polytec kaufen | Warburg Research | |
| 15.12.25 | Raiffeisen | Erste Group Bank | |
| 15.12.25 | Sanofi Neutral | JP Morgan Chase & Co. | |
| 15.12.25 | TAG Immobilien Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 15.12.25 | TKMS thyssenkrupp Marine Systems Buy | Deutsche Bank AG | |
| 15.12.25 | PATRIZIA Buy | Deutsche Bank AG | |
| 15.12.25 | Carl Zeiss Meditec Hold | Deutsche Bank AG | |
| 15.12.25 | Nike Neutral | UBS AG | |
| 15.12.25 | Unilever Outperform | Bernstein Research | |
| 15.12.25 | BAT Overweight | Barclays Capital | |
| 15.12.25 | Richemont Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 15.12.25 | Kering Sell | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 15.12.25 | LVMH Moet Hennessy Louis Vuitton Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 15.12.25 | Hermès Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 15.12.25 | Zalando Outperform | RBC Capital Markets | |
| 15.12.25 | UBS Overweight | JP Morgan Chase & Co. | |
| 15.12.25 | Carl Zeiss Meditec Underweight | JP Morgan Chase & Co. | |
| 15.12.25 | T-Mobile US Overweight | JP Morgan Chase & Co. | |
| 15.12.25 | Sartorius Stedim Biotech Overweight | JP Morgan Chase & Co. | |
| 15.12.25 | Sartorius vz. Overweight | JP Morgan Chase & Co. | |
| 15.12.25 | Symrise Overweight | JP Morgan Chase & Co. | |
| 15.12.25 | HelloFresh Equal Weight | Barclays Capital | |
| 12.12.25 | Fraport Hold | Jefferies & Company Inc. | |
| 12.12.25 | thyssenkrupp Halten | DZ BANK | |
| 12.12.25 | Schneider Electric Equal Weight | Barclays Capital | |
| 12.12.25 | Linde Buy | Jefferies & Company Inc. | |
| 12.12.25 | BNP Paribas Equal Weight | Barclays Capital | |
| 12.12.25 | Meta Platforms Overweight | JP Morgan Chase & Co. | |
| 12.12.25 | Amazon Overweight | JP Morgan Chase & Co. | |
| 12.12.25 | Alphabet A Overweight | JP Morgan Chase & Co. | |
| 12.12.25 | Oracle Kaufen | DZ BANK | |
| 12.12.25 | Beiersdorf Kaufen | DZ BANK | |
| 12.12.25 | Nike Buy | Jefferies & Company Inc. | |
| 12.12.25 | Linde Buy | Deutsche Bank AG | |
| 12.12.25 | Roche Hold | Deutsche Bank AG | |
| 12.12.25 | HUGO BOSS Hold | Deutsche Bank AG | |
| 12.12.25 | Carl Zeiss Meditec Hold | Deutsche Bank AG | |
| 12.12.25 | Schneider Electric Buy | Deutsche Bank AG | |
| 12.12.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 12.12.25 | Givaudan Buy | Deutsche Bank AG | |
| 12.12.25 | SAF-HOLLAND Kaufen | DZ BANK |
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.